Atrium Therapeutics (RNA) Q3 2023 Earnings

Nov 8Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.89
-0.81
-0.74
-0.66

Details

Expected EPS
-0.77
Actual EPS
-0.71
Surprise EPS
0.06
Surprise Percent
+7.79%

Description

⁨Atrium Therapeutics⁩ (⁦RNA⁩) has reported earnings of ⁦-0.71⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts